Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comprehensive Immunophenotyping of CSF cells in relapsing-remitting multiple sclerosis patients with daclizumb therapy
Genentech and Biogen Idec announce top-line results from a Phase II/III clinical trial of Rituxan in primary-progressive multiple sclerosis
Barcelona Pediatric MS and Related Disorders Update Meeting
Subcutaneous recombinant interferon-β-1a (Rebif®): a review of its use in the treatment of relapsing multiple sclerosis.
Posturography in MS patients treated with high dose methylprednisolone.
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
Primary Progressive MS evolving from Radiologically Isolated Syndrome.
DNA strand breakage by peroxidase-activated mitoxantrone.
PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate.
Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.
A gender gap in autoimmunity.
Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells.
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study.
European Medicines Agency, Scientific Discussion of MabCampath (alemtuzumab)
Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b.
Clinical proteomics of enervated neurons.
Charcot-Marie-Tooth 1A: a narrative review with clinical and anatomical perspectives.
National MS Society: Ralph I. Straus Award
Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials.
Microcystic macular oedema in multiple sclerosis is associated with disease severity.
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.
A Unified Frequency Domain Model to Study the Effect of Demyelination on Axonal Conduction.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.
[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
Pages
« first
‹ previous
…
87
88
89
90
91
92
93
94
95
…
next ›
last »